The United States Food and Drug Administration (FDA) approved the drug flibanserin (sold under the brand name Addyi) for the treatment of women with hypo-active sexual desire disorder (HSDD) in August 2015. Australia hasn’t followed suit, though flib
Most women and their partners are offered or recommended childbirth education classes as part of routine care during pregnancy. Most first-time parents attend these classes but this declines considerably for following pregnancies, although there is n